Prelude Therapeutics Incorporated (PRLD) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 161.86M |
| Enterprise Value | 144.4M |
| P/E Ratio | -8.39 |
| PEG Ratio | -0.1 |
| Price/Sales Ratio | 12.21 |
| Price/Book Ratio | 4.88 |
| Enterprise/Revenue | 11.82 |
| Enterprise/EBITDA | -4.5 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | -2.7 |
| Operating Margin | -3.01 |
| Return On Assets | -0.32 |
| Return On Equity | -0.75 |
| Revenue | 12.14M |
| Revenue/Share | 0.23 |
| Gross Profit | 10.43M |
| EBITDA | -97.79M |
| Net Income | -99.5M |
| Diluted EPS | -1.29 |
| Total Cash | 151.76M |
| Total Cash/Share | 1.54 |
| Total Debt | 17.65M |
| Total Debt/Equity | 0.13 |
| Current Ratio | 4.07 |
| Book Value Per Share | 1.36 |
| 52-Week Change | 434.68 |
| 52-Week High | 6.82 |
| 52-Week Low | 0.98 |
| Moving Average 50 Days | 4.73 |
| Moving Average 200 Days | 3.4 |
| Average Volume | 462,500 |
| Shares Outstanding | 78.5M |
| % Held by Institutions | 37.29 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |